Meet the Drapers: New Reality TV Series Where Viewers Can Invest in Startups.

First-Ever Crowdfunding TV Show "Meet the Drapers" Premieres on Sony Entertainment Television November 19th, 2017

NEW YORK, Nov. 17, 2017 /PRNewswire/ -- Ever watch your favorite investment show and wish you could get in on the action, too? Now you can! In the new reality series, "Meet the Drapers", millions of viewers will be able to invest alongside the sharks — the Draper family, Silicon Valley's top venture capitalists.

Meet the Drapers, the first series of its kind, allows regular people to become investors — right from their couch, while watching the show. This unique angle is made possible by the recent SEC regulations that for the first time opened investment crowdfunding to the public.

Investments will take place through the equity crowdfunding platform Republic, which has announced it will be Meet the Drapers' official investment platform.

"Republic's partnership is instrumental for the show's success," says producer Sarika Batra. "No other platform out there makes investing as friendly and easy, which is critical for the – often first-time – investors watching the show."

"Crowdfunding is removing barriers like never before," says Republic CEO, Kendrick Nguyen. "What was once viewed as an industry for a selected few is now accessible to everyone. And we're thrilled to be part of a TV show that promotes entrepreneurship and enables greater diversity among both founders and investors."

"South Asians – the show's core audience – are a vibrant part of the Silicon Valley startup culture," says Jaideep Janakiram, Head of the Americas at Sony Pictures Networks. "We created this show to showcase these trailblazing entrepreneurs, VCs and angels, and to allow our viewers to participate in their ventures.

"Meet the Drapers" is produced by Sarika Batra and is airing in partnership with the Draper Family, Sony Entertainment Television (SET) and Republic and sponsored by ICO Investor.tv.

The series premieres Sunday, November 19 at 6PM ET on Sony Entertainment Television. SET is a paid channel on Dish network, Sling TV and major cable providers — please check your local listings.

About Republic:
Republic launched in 2016 with a mission to democratize investing. A leading equity crowdfunding platform and sister company of AngelList, Product Hunt and CoinList, Republic is part of one of the most prominent startup ecosystems in the world. On Republic, anyone can invest in breakout early-stage startups for as little as $10 in just a few minutes, using their credit card or bank account.

About Sony Entertainment Television:
Sony Entertainment Television (SET), one of India's leading Hindi general entertainment television channels is a part of Sony Pictures Television (SPT) backed Sony Pictures Networks, which is India'sleading television network. Since its launch in October 1995, SET has created a unique space for itself in the Indian Television industry. Pioneering new waves in television programming, with blockbuster movie premieres, big format non-fiction shows and an impressive array of fiction shows like Sabse Bada Kalakar, Super Dancer, The Kapil Sharma Show, Indian Idol, Kaun Banega Crorepati, Entertainment Ke Liye Kuch Bhi Karega, Sankat Mochan Mahabali Hanuman, Beyhadh, Kuch Rang pyre Ke Aise Bhi, Bajirao Peshwa, CID, Crime Patrol Bade Acche Lagte Hain, Bharat Ka Veer Putra Maharana Pratap and Itna Karo Na Mujhe Pyar. SET is known for its innovative concepts and exciting formats and is the most preferred family entertainment channel which has been providing strong platforms for more than 700 brands to reach over 93 million households in India. In addition, Sony Entertainment Television is also available in the US, UK, Africa, Europe, Canada, Australia, New Zealand, Singapore, Pakistan, Nepal, Bangladesh, Maldives, Malaysia, Indonesia, Fiji Islands and Seychelles. In total, SET influences over 332 million viewers in the Indian sub-continent, and the South Asian Diaspora worldwide.

About ICO Investor.tv:
ICO Investor.tv is the title sponsor of the show. They are a trusted source of information for Initial Coin Offerings (ICOs) enthusiasts and ICO investors. Their sister site, NextGen Crowdfunding will provide data for all campaigns on the show, and a live Crowdfunding Ticker will display updates on investor commitments for each campaign. Through the Meet the Drapers dashboard, viewers can "follow" and track the deals they are most interested in.

More information on the show please visit setasia.tv/meetthedrapers. 
Show website: http://meetthedrapers.com/ 
Detailed information on participating startups can be found on republic.co/meet-the-drapers.

Media contacts:

Republic  Peter Green  peter@republic.co  republic.co

Sarika Batra Productions Seema Sharma seema@meetthedrapers.com

Sony Pictures Networks Puja Shah Puja_shah@spe.sony.com www.setasia.tv

 

View original content with multimedia:http://www.prnewswire.com/news-releases/meet-the-drapers-new-reality-tv-series-where-viewers-can-invest-in-startups-300558820.html

SOURCE Republic

Web Site: http://meetthedrapers.com 

Convocation - Une nouvelle place publique au cœur de Montréal - Remise d'un des legs du gouvernement du Québec à la Ville de Montréal dans le cadre de son 375e anniversaire

MONTRÉAL, le 17 nov. 2017 /CNW Telbec/ - Le ministre des Transports, de la Mobilité durable et de l'Électrification des transports, M. André Fortin, la mairesse de Montréal, M^me Valérie Plante, et le député de D'Arcy McGee, monsieur David Birnbaum, au nom du ministre des Affaires municipales et de l'Occupation du territoire, ministre de la Sécurité publique et ministre responsable de la région de Montréal, M. Martin Coiteux, invitent les représentants des médias à assister à une cérémonie soulignant l'inauguration d'une nouvelle place publique au-dessus de l'autoroute 720 (Ville-Marie).

 

DATE :	Le lundi 20 novembre 2017
HEURE :	10 h
LIEU :	Édicule de la station de métro Champ-de-Mars
	940, rue Sanguinet
	Montréal, Qc

 

SOURCE Cabinet du ministre des Transports, de la Mobilité durable et de l'Électrification des transports

CONTACT: Marie-Pier Richard, Attachée de presse, Cabinet du ministre des Transports, de la Mobilité durable et de l'Électrification des transports, 418 643-6980 

Agrium and PotashCorp Announce Mailing of Letters of Transmittal and Election Forms to Registered Shareholders in Connection with Merger of Equals Transaction

SASKATOON and CALGARY, Nov. 17, 2017 /PRNewswire/ - Potash Corporation of Saskatchewan Inc. (PotashCorp) (TSX and NYSE: POT) and Agrium Inc. (Agrium) (TSX and NYSE: AGU) today announced the mailing of the letters of transmittal and election forms in connection with the proposed merger of equals transaction to their respective registered shareholders.

Each company's letter of transmittal and election form outlines the necessary documentation and information required to be sent to the depositary for the transaction, AST Trust Company (Canada) (the "Depositary"), by a registered shareholder in order to receive the shares of the parent entity, Nutrien Ltd., to which they are entitled in exchange for their Agrium or PotashCorp common shares, as applicable, once the transaction is completed and, if eligible, to make an election in respect of their shares.

The letters of transmittal and election forms are for use by registered shareholders only. Beneficial shareholders that do not have their common shares of Agrium or PotashCorp registered in their name (rather, such shares are registered in the name of a broker or other intermediary) should contact their broker or other intermediary for instructions and assistance regarding receipt of any shares of Nutrien Ltd. to which they are entitled once the transaction is completed or, if eligible, to make an election in respect of their shares.

Agrium's letter of transmittal and election form will be available on Agrium's website at www.agrium.com, and PotashCorp's letter of transmittal and election form will be available on PotashCorp's website at www.potashcorp.com, and both letters of transmittal will be available on the merger website of Agrium and PotashCorp at www.worldclasscropinputsupplier.com. Copies of the applicable letter of transmittal and election form will also be available under Agrium's and PotashCorp's respective profiles on SEDAR at www.sedar.com and the Securities and Exchange Commission's website at www.sec.gov. Additional copies of the letters of transmittal are also available by contacting Kingsdale Advisors at contactus@kingsdaleadvisors.com.

The letters of transmittal and election forms also provide eligible Canadian residents that are registered Agrium and PotashCorp shareholders with the ability to make an election to have the exchange of their Agrium or PotashCorp shares carried out in such a manner that may allow such shareholders to defer the realization of any accrued capital gain or a capital loss for Canadian federal income tax purposes (without the need to complete any tax election forms).  See "Part I – The Arrangement - Certain Canadian Federal Income Tax Considerations" of the joint information circular of Agrium and PotashCorp dated October 3, 2016 for further information with respect to such election. As noted in the joint information circular, shareholders should consult their own tax advisors for advice in respect of the consequences to them of the transaction having regard to their particular circumstances.

Any letter of transmittal and election form deposited with the Depositary will be revocable up to the election deadline by written notice or by filing a later-dated letter of transmittal received by the Depositary prior to the election deadline. A letter of transmittal and election form may not be withdrawn by a shareholder after the election deadline. Agrium and PotashCorp will announce the election deadline in a press release disseminated through nationally recognized wire services in Canada and the United Statesat least six business days prior to such deadline.

As previously announced, Agrium and PotashCorp have obtained the necessary shareholder and court approvals required to meet certain conditions to the completion of the transaction, but completion of the transaction remains conditional on the satisfaction of the remaining regulatory and other customary conditions. Agrium and PotashCorp expect to close the transaction by the end of the fourth quarter of 2017. In the event that the transaction is not completed, any share certificates delivered to the Depositary will be returned.

About Agrium
Agrium Inc. is a major global producer and distributor of agricultural products, services and solutions. Agrium produces nitrogen, potash and phosphate fertilizers, with a combined wholesale nutrient capacity of close to 11 million tonnes and with significant competitive advantages across our product lines. We supply key products and services directly to growers, including crop nutrients, crop protection, seed, as well as agronomic and application services, thereby helping growers to meet the ever growing global demand for food and fiber. Agrium retail-distribution has an unmatched network of approximately 1,500 facilities and over 3,300 crop consultants who provide advice and products to our grower customers to help them increase their yields and returns on hundreds of different crops. With a focus on sustainability, the company strives to improve the communities in which it operates through safety, education, environmental improvement and new technologies such as the development of precision agriculture and controlled release nutrient products. Agrium is focused on driving operational excellence across our businesses, pursuing value-enhancing growth opportunities and returning capital to shareholders. For more information visit: www.agrium.com

About PotashCorp
PotashCorp is the world's largest crop nutrient company and plays an integral role in global food production. The company produces the three essential nutrients required to help farmers grow healthier, more abundant crops. With global population rising and diets improving in developing countries, these nutrients offer a responsible and practical solution to meeting the long-term demand for food. PotashCorp is the largest producer, by capacity, of potash and one of the largest producers of nitrogen and phosphate. While agriculture is its primary market, the company also produces products for animal nutrition and industrial uses. Common shares of Potash Corporation of Saskatchewan Inc. are listed on the Toronto Stock Exchange and the New York Stock Exchange.

Forward-Looking Statements

Certain statements and other information included in this press release constitute "forward-looking information" or "forward-looking statements" (collectively, "forward-looking statements") under applicable securities laws. All statements in this press release, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to the completion of the proposed transaction, including timing thereof, and the anticipated tax treatment of the proposed transaction.

Forward-looking statements in this press release are based on certain key expectations and assumptions made by Agrium and PotashCorp, including expectations and assumptions concerning the time necessary to satisfy the conditions to the closing of the transaction. These dates may change for a number of reasons, including the need for additional time to satisfy the regulatory and other customary conditions to the completion of the transaction. Although Agrium and PotashCorp believe that the expectations and assumptions on which such forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because Agrium and PotashCorp can give no assurance that they will prove to be correct. 

Agrium and PotashCorp disclaim any intention or obligation to update or revise any forward-looking statements in this press release as a result of new information or future events, except as may be required under applicable U.S. federal securities laws or applicable Canadian securities legislation.

Additional Information and Where to Find It

Additional information about Agrium and PotashCorp can be found under their respective corporate profiles on SEDAR at www.sedar.com or on EDGAR at www.sec.gov, respective websites at www.agrium.com and www.potashcorp.com, or by contacting the contacts below.

SOURCE Potash Corporation of Saskatchewan Inc.

CONTACT: Agrium Contacts: Investor/Media Relations: Richard Downey, Vice President, Investor & Corporate Relations, (403) 225-7357; Todd Coakwell, Director, Investor Relations, (403) 225-7437, aginvest@agrium.com; PotashCorp Contacts: Investors: Denita Stann, Senior Vice President, Investor and Public Relations, (306) 933-8521, IR@potashcorp.com; Media: Randy Burton, Director, Public Relations and Communications, (306) 933-8849 

Web Site: http://www.potashcorp.com 

Technical Snapshots for These Biotech Stocks -- Dynavax Technologies, Keryx Biopharma, Moleculin Biotech, and TG Therapeutics

NEW YORK, Nov. 17, 2017 /PRNewswire/ -- If you want a Stock Review on DVAX, KERX, MBRX, or TGTX then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Biotech companies are mainly involved in developing new drug treatments, tests, and other medical technologies. The sector is notoriously volatile in large part, because investors are often banking on a firm's latest drug or treatment receiving regulatory approval where the chances of success are low. For today, research reports have been issued by DailyStockTracker.com on Dynavax Technologies Corp. (NASDAQ: DVAX), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Moleculin Biotech Inc. (NASDAQ: MBRX), and TG Therapeutics Inc. (NASDAQ: TGTX). Access DailyStockTracker.com's complimentary reports for today's stocks line-up at: http://dailystocktracker.com/register/

Dynavax Technologies

Shares in Berkeley, California headquartered Dynavax Technologies Corp. rose 3.36%, ending Thursday's trading session at $18.45. The stock recorded a trading volume of 1.87 million shares. The Company's shares have gained 13.89% over the last three months and 367.09% on an YTD basis. The stock is trading 59.52% above its 200-day moving average. Moreover, shares of Dynavax Technologies, which focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation, have a Relative Strength Index (RSI) of 38.53.  

On November 09^th, 2017, Dynavax Technologies announced that the US Food and Drug Administration has approved HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. HEPLISAV-B is the first new hepatitis B vaccine in the US in more than 25 years and the only two-dose hepatitis B vaccine for adults. Visit us today and access your complete report on DVAX for free at: http://dailystocktracker.com/registration/?symbol=DVAX

Keryx Biopharmaceuticals

Boston, Massachusetts headquartered Keryx Biopharmaceuticals Inc.'s stock dropped 3.18%, closing the day at $4.87. A total volume of 2.83 million shares was traded, which was above their three months average volume of 1.70 million shares. The Company's shares are trading 23.66% below their 200-day moving average. Additionally, shares of Keryx Biopharma, which focuses on providing medicines for patients with renal disease in the US, have an RSI of 35.49. 

On November 07^th, 2017, Keryx Biopharmas announced that the US FDA has approved Auryxia for an additional indication. The approval is for the treatment of iron deficiency anemia in adults with chronic kidney disease, not on dialysis. Auryxia was originally approved in September 2014 for the control of serum phosphorus levels in people with chronic kidney disease who require dialysis. The complimentary research report on KERX can be accessed at: http://dailystocktracker.com/registration/?symbol=KERX

Moleculin Biotech

On Thursday, shares in Houston, Texas headquartered Moleculin Biotech Inc. recorded a trading volume of 182,887 shares. The stock ended the day 1.87% higher at $1.63. The Company's shares are trading below their 200-day moving average by 0.44%. Furthermore, shares of Moleculin Biotech, which focuses on the development of anti-cancer drug candidates, have an RSI of 36.38.  

On November 01^st, 2017, Moleculin Biotech announced that responses to US FDA requests for additional information relating to the physician-sponsored Investigational New Drug ("IND") application to study WP1066 as a potential treatment for brain tumors have been submitted. As the Company has disclosed previously, the IND had been placed on clinical hold pending satisfactory responses to questions provided by the FDA. Register for free on DailyStockTracker.com and download the research report on MBRX at: http://dailystocktracker.com/registration/?symbol=MBRX

TG Therapeutics

New York headquartered TG Therapeutics Inc.'s stock declined 1.78%, finishing yesterday's session at $8.30. A total volume of 2.09 million shares was traded, which was above their three months average volume of 1.21 million shares. The Company's shares have advanced 4.40% in the last one month and 78.49% on an YTD basis. The stock is trading below its 50-day moving average by 18.27%. Additionally, shares of TG Therapeutics, which focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the US, have an RSI of 44.36.  

On November 08^th, 2017, TG Therapeutics announced its financial results for the three months ended September 30^th, 2017. R&D expenses for Q3 2017 were $27.1 million, G&A expenses were $4.5 million, and net loss was $31.5 million. Cash, cash equivalents, investment securities, and interest receivable were $91.8 million as of September 30^th, 2017.

On November 14^th, 2017, research firm H.C. Wainwright resumed its 'Buy' rating on the Company's stock, with a target price of $33 per share. Get free access to your research report on TGTX at: http://dailystocktracker.com/registration/?symbol=TGTX

Daily Stock Tracker:

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@dailystocktracker.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY

DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://dailystocktracker.com/disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: 
Email: contact@dailystocktracker.com 
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa 

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

 

View original content:http://www.prnewswire.com/news-releases/technical-snapshots-for-these-biotech-stocks----dynavax-technologies-keryx-biopharma-moleculin-biotech-and-tg-therapeutics-300558458.html

SOURCE Morris Capital Inc

CONTACT: Tom Johnson, anewmedias@gmail.com 

Web Site: http://dailystocktracker.com 

Programme Réhabilitation du réseau routier local - Volet redressement des infrastructures routières locales - Québec accorde une aide financière de plus de 352 000 $ à la Ville de Louiseville

LOUISEVILLE, QC, le 17 nov. 2017 /CNW Telbec/ - Le gouvernement du Québec attribue une aide financière maximale de 352 190 $ à la Ville de Louiseville, située dans la circonscription de Maskinongé, pour le décohésionnement, l'asphaltage et le rechargement d'accotements sur l'avenue Royale nord.

Le député de Maskinongé et adjoint parlementaire du premier ministre pour les régions, M. Marc H. Plante, en a fait l'annonce au nom du ministre des Transports, de la Mobilité durable et de l'Électrification des transports, M. André Fortin. Pour sa part, la Ville participe au financement de ce projet pour un montant de 39 131 $, soit 10 % du coût total du projet qui s'élève à 391 321 $.

Les travaux consistent dans le décohésionnement, l'asphaltage et le rechargement d'accotements de l'avenue Royale nord et visent à maintenir la route en bon état et à assurer la sécurité des usagers qui l'empruntent. Ce projet s'inscrit dans le cadre du programme Réhabilitation du réseau routier local - Volet Redressement des infrastructures routières locales.

Citations :

« Notre appui financier à la voirie locale nous permet d'accompagner les municipalités dans leurs besoins en matière de maintien et d'amélioration des infrastructures routières locales. Je suis heureux d'annoncer aujourd'hui que le gouvernement apporte ce soutien financier à la Ville de Louiseville. »

André Fortin, ministre des Transports, de la Mobilité durable et de l'Électrification des transports

« Cet appui démontre l'importance du partenariat qui existe entre les municipalités et le gouvernement du Québec. Lorsque ces travaux seront terminés, les usagers bénéficieront de routes plus sécuritaires qui permettront de maintenir le lien avec les municipalités limitrophes et un meilleur accès aux attraits touristiques situés dans la circonscription de Maskinongé. »

Julie Boulet, ministre responsable de la région de la Mauricie

« Par cette aide financière, le gouvernement démontre que la sécurité routière est une priorité. Je me réjouis que le choix des travaux visant la pérennité du réseau routier local, l'entretien des infrastructures et des routes s'appuie sur les choix et les priorités des élus locaux. »     

Marc H. Plante, député de Maskinongé et adjoint parlementaire du premier ministre pour les régions

Faits saillants :

Le programme Réhabilitation du réseau routier local :

• est doté d'une enveloppe de 50 millions de dollars pour 2017-2018;
• comprend deux volets :
• Accélération des investissements sur le réseau routier local,
• Redressement des infrastructures routières locales;
• vise à financer des travaux d'amélioration et à assurer la sécurité des usagers sur le réseau routier local de niveaux 1 et 2;
• s'adresse aux municipalités de moins de 100 000 habitants, de même qu'aux MRC qui ont des interventions à réaliser sur leurs territoires non organisés.

Lien connexe :
Ministère des Transports, de la Mobilité durable et de l'Électrification des transports : transports.gouv.qc.ca.

Suivez-nous sur Facebook et Twitter.

 

SOURCE Cabinet du ministre des Transports, de la Mobilité durable et de l'Électrification des transports

CONTACT: Marie-Pier Richard, Attachée de presse, Cabinet du ministre des Transports, de la Mobilité durable et de l'Électrification des transports, Tél. : 418 643-6980 ; Louis-Maxim Toutant, Conseiller politique, Bureau du député de Maskinongé, Tél. : 819 228-9722 ; Pour information : Relations avec les médias, Direction des communications, Ministère des Transports, de la Mobilité durable et de l'Électrification des transports, Tél. : Québec : 418 644-4444, Montréal : 514 873-5600, Sans frais : 1 866 341-5724 

CBS Corporation Announces Preliminary Results Of CBS Radio Exchange Offer

NEW YORK, Nov. 17, 2017 /PRNewswire/ -- CBS Corporation (NYSE: CBS.A and CBS) ("CBS") today announced that its previously announced offer to shareholders to exchange their shares of CBS Class B common stock on a per-share-basis for 5.6796 shares of CBS Radio Inc. ("CBS Radio") common stock expired at 11:59 p.m., New York City time, on November 16, 2017, and based on preliminary results, the exchange offer was oversubscribed. The exchange offer to split-off CBS Radio is part of CBS' agreement to combine its radio business with Entercom Communications Corp. (NYSE: ETM) ("Entercom").

According to the exchange agent for the exchange offer, Wells Fargo Bank, N.A., 165,743,402 shares of CBS Class B common stock were tendered prior to the expiration of the exchange offer, including 64,125,859 shares of CBS Class B common stock validly tendered and 101,617,543 shares of CBS Class B common stock that were tendered by notice of guaranteed delivery. CBS has accepted 17,854,689 of the tendered shares of CBS Class B common stock in exchange for 101,407,494 shares of CBS Radio common stock. In addition, following the merger, Entercom common stock will be eligible for issuance in respect of equity awards held by employees of CBS Radio in consideration of the replacement of their restricted stock units and stock options in CBS. Immediately following the consummation of the exchange offer, in connection with the merger of CBS Radio with a wholly owned subsidiary of Entercom, each share of CBS Radio common stock is being converted into the right to receive one share of Entercom Class A common stock (with cash in lieu of fractional shares).

Because the exchange offer was oversubscribed, CBS accepted tendered shares of CBS Class B common stock on a pro rata basis in proportion to the total number of shares tendered and not validly withdrawn. Shareholders who owned fewer than 100 shares of CBS Class B common stock, or an "odd lot," and who validly tendered all of their shares, are not subject to proration in accordance with the terms of the exchange offer.

Based on the total number of shares of CBS Class B common stock that were reported as tendered prior to the expiration of the exchange offer, it is estimated that approximately 10.12% of the tendered shares of CBS Class B common stock that are subject to proration will be exchanged for shares of CBS Radio common stock, assuming all shares tendered by guaranteed delivery procedures are delivered under the terms of the exchange offer. The preliminary proration factor is subject to change based on the number of tendered shares that satisfy the guaranteed delivery procedures.

CBS expects to announce the final proration factor as soon as possible following the expiration of the guaranteed delivery period, which will occur on November 20, 2017. Promptly after the final proration factor is announced, shares of CBS Class B common stock tendered but not accepted for exchange will be returned to the tendering shareholders in book-entry form. Also at that time, the exchange agent for the exchange offer will deliver to Entercom's transfer agent a final shareholder list for CBS Radio common stock received by tendering CBS Class B common stock shareholders whose shares were accepted for exchange in the exchange offer. Entercom's transfer agent will use the final shareholder list to credit such shareholders with an equal number of whole shares of Entercom Class A common stock. Fractional shares of Entercom Class A common stock due to tendering CBS Class B common stock shareholders will be aggregated and sold in the open market by Entercom's transfer agent. Checks in lieu of fractional shares will thereafter be delivered to such tendering CBS Class B common stock shareholders by Entercom's transfer agent.

Forward-Looking Statements  
This press release contains certain statements about CBS, CBS Radio and Entercom that are "forward-looking statements" within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended. These matters involve risks and uncertainties as discussed in CBS' and Entercom's respective periodic reports on Form 10-K and Form 10-Q and current reports on Form 8-K, filed from time to time with the SEC. The forward-looking statements contained in this press release may include statements about the expected effects on CBS, CBS Radio and Entercom of the separation of CBS' radio business and merger of CBS Radio with an Entercom subsidiary (collectively, the "Transaction"); the anticipated benefits of the Transaction and CBS', CBS Radio's and Entercom's anticipated financial results; and also include all other statements in this press release that are not historical facts. Without limitation, any statements preceded or followed by or that include the words "targets," "plans," "believes," "expects," "intends," "will," "likely," "may," "anticipates," "estimates," "projects," "should," "would," "could," "positioned," "strategy," "future," or words, phrases, or terms of similar substance or the negative thereof, are forward-looking statements. These statements are based on the current expectations of the management of CBS, CBS Radio and Entercom (as the case may be) and are subject to uncertainty and to changes in circumstances and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. In addition, these statements are based on a number of assumptions that are subject to change. Such risks, uncertainties and assumptions include: the anticipated tax treatment of the Transaction and related transactions; risks relating to any unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, and future prospects; business and management strategies; the expansion and growth of Entercom's operations; ongoing risks related to the price or trading volume of Entercom's common stock; failure to pay dividends to holders of Entercom's common stock; impairment charges for FCC licenses and goodwill; Entercom's ability to integrate CBS Radio's business successfully after the closing of the Transaction and to achieve anticipated synergies; and the risk that disruptions from the Transaction will harm CBS', CBS Radio's or Entercom's businesses. However, it is not possible to predict or identify all such factors. Consequently, while the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Forward-looking statements included herein are made as of the date hereof, and none of CBS, CBS Radio or Entercom undertakes any obligation to update publicly such statements to reflect subsequent events or circumstances.

About CBS Corporation 
CBS Corporation (NYSE: CBS.A and CBS) is a mass media company that creates and distributes industry-leading content across a variety of platforms to audiences around the world. The Company has businesses with origins that date back to the dawn of the broadcasting age as well as new ventures that operate on the leading edge of media. CBS owns the most-watched television network in the U.S. and one of the world's largest libraries of entertainment content, making its brand — "the Eye" — one of the most recognized in business. The Company's operations span virtually every field of media and entertainment, including cable, publishing, local TV, film, and interactive and socially responsible media. CBS' businesses include CBS Television Network, The CW (a joint venture between CBS Corporation and Warner Bros. Entertainment), CBS Television Studios, CBS Studios International, CBS Television Distribution, CBS Consumer Products, CBS Home Entertainment, CBS Interactive, CBS Films, Showtime Networks, CBS Sports Network, Pop (a joint venture between CBS Corporation and Lionsgate), the properties of Network TEN in Australia, Smithsonian Networks, Simon & Schuster, CBS Television Stations, and CBS EcoMedia. For more information, go to www.cbscorporation.com.

View original content:http://www.prnewswire.com/news-releases/cbs-corporation-announces-preliminary-results-of-cbs-radio-exchange-offer-300558456.html

SOURCE CBS Corporation

CONTACT: Press: Judy DeHaven, CBS Corporation, (212) 975-1942, jdehaven@cbs.com; Jaime Saberito, CBS Radio, (212) 649-9639, jaime.saberito@cbsradio.com; Investors: Adam Townsend, CBS Investor Relations, (212) 975-5292, adam.townsend@cbs.com; David Bank, CBS Investor Relations, (212) 975-6106, david.bank@cbs.com 

Web Site: http://www.cbscorporation.com 

From Universal Pictures Home Entertainment: Marshall

Chadwick Boseman, Kate Hudson, Josh Gad, Dan Stevens, Sterling K. Brown, And James Cromwell Star In The Powerful Civil Rights Drama

Based On The Incredible True Story Of The Rise Of Future Supreme Court Justice Thurgood Marshall

"Powerful And Electrifying…A Fiercely Entertaining Film" - Peter Travers, Rolling Stone

Available On Digital December 26, 2017 And Blu-ray™ And DVD January 9, 2018 From Universal Pictures Home Entertainment

PR Newswire

UNIVERSAL CITY, Calif., Nov. 17, 2017

UNIVERSAL CITY, Calif., Nov. 17, 2017 /PRNewswire/ -- The fate of the defendant lies within the truth in the gripping and illuminating story Marshall, coming to Digital on December 26, 2017 and Blu-ray^™, DVD and On Demand on January 9, 2018, from Universal Pictures Home Entertainment. A thrilling whodunit, Marshall stars Chadwick Boseman (Black Panther), Josh Gad (Murder on the Orient Express), Kate Hudson (Almost Famous) and two-time Primetime Emmy award-winner Sterling K. Brown ("This Is Us") delivering what critics call "Oscar-worthy performances in one of the most important films of the year" (Rachel Smith, FOX). Fifty years after Thurgood Marshall was sworn in as the first African American Supreme Court Justice in 1967, this riveting and timely film invites audiences to discover an untold chapter of an inspirational figure who shaped modern American history and serves as a moving reminder of contemporary race relations.
Marshall is based on the incredible true story of future Supreme Court Justice Thurgood Marshall and one of the landmark cases of his life.  It follows the young lawyer (Boseman) to conservative Connecticutto defend a black chauffeur (Brown) charged with sexual assault and attempted murder of his white socialite employer (Hudson). Muzzled by a segregationist court, Marshall partners with a courageous young Jewish lawyer (Gad) and together they mount the defense in an environment of racism and anti-Semitism.
Winner of the Chicago International Film Festival Audience Award, Marshall also features outstanding performances from Dan Stevens (Downton Abbey), Oscar® nominee James Cromwell (The Young Pope), Sophia Bush ("Chicago P.D."), and Jussie Smollett ("Empire"). Featured in the film is also the Hollywood Film Award winning original song "Stand Up For Something," performed by Andra Day and featuring Academy Award and Grammy Award winning musician Common.

For artwork, please log onto our website at www.ushepublicity.com
Website: http://uni.pictures/marshall
Trailer: http://uni.pictures/marshalltrailer
Facebook: https://www.facebook.com/MarshallMovie
Twitter: https://twitter.com/MarshallMovie
Instagram: https://www.instagram.com/MarshallMovie/
#MarshallMovie, #StandUpForSomething

FILMMAKERS:Cast: Chadwick Boseman, Josh Gad, Kate Hudson, Dan Stevens, Sterling K. Brown, and James Cromwell
Casting By: Victoria Thomas _CSA, Kathleen Chopin _CSACostume Designer: Ruth E. Carter
Music Supervisor: Mary Ramos
Music By: Marcus Miller
Editor: Tom McArdle _ACEProduction Designer: Richard Hoover
Director of Photography: Newton Thomas Sigel _ASCExecutive Producers: Lei Luo, Xu Yan, Chris Bongirne, Hunter Ryan, David Ryan, Tom Ortenberg, John Cappetta, Kevin Lamb, Lai Pan, Lili Sun
Produced By: Paula Wagner, _p.g.a., Jonathan Sanger, _p.g.a., Reginald Hudlin, _p.g.a.Written By: Michael Koskoff and Jacob Koskoff
Directed By: Reginald Hudlin
ORIGINAL SONG "STAND UP FOR SOMETHING"Music by: Diane Warren
Lyrics by: Diane Warren and Common
Performance by: Andra Day, Featuring Common
TECHNICAL INFORMATION BLU-RAY^™:Street Date: January 9, 2018
Copyright: Universal Pictures Home Entertainment
Selection Number: 55192098
Layers: BD 50
Aspect Ratio: 16:9 Widescreen
Rating: PG-13 for mature thematic content, sexuality, violence and some strong language
Languages/Subtitles: English SDH, Latin American Spanish
Sound: English DTS-HD Master Audio 5.1
Run Time: 1 hour, 58 minutes
TECHNICAL INFORMATION DVD:Street Date: January 9, 2018
Copyright: Universal Pictures Home Entertainment
Selection Number: 55192099
Layers: DVD 9
Aspect Ratio: 16:9 Anamorphic Widescreen
Rating: PG-13 for mature thematic content, sexuality, violence and some strong language
Languages/Subtitles: English SDH, Latin American Spanish
Sound: English Dolby Digital 5.1
Run Time: 1 hour, 58 minutes
About Universal Pictures Home EntertainmentUniversal Pictures Home Entertainment (UPHE – www.uphe.com) is a unit of Universal Pictures, a division of Universal Studios. Universal Studios is a part of NBCUniversal, one of the world's leading media and entertainment companies in the development, production, and marketing of entertainment, news, and information to a global audience. NBCUniversal owns and operates a valuable portfolio of news and entertainment television networks, a premier motion picture company, significant television production operations, a leading television stations group, world-renowned theme parks, and a suite of leading Internet-based businesses. NBCUniversal is a subsidiary of Comcast Corporation.
CONTACT:Azure Anderson
Assistant Manager, Global Publicity
Universal Pictures Home Entertainment
Azure.Anderson@nbcuni.com

View original content with multimedia:http://www.prnewswire.com/news-releases/from-universal-pictures-home-entertainment-marshall-300558410.html

SOURCE Universal Pictures Home Entertainment

Web Site: http://www.uphe.com

When Gas Prices Fluctuate, Businesses Can Easily Save Money by Tracking With Mobile Interactive Route

CarData's Mi-Route mobile app can help save 17% in gas expenses for company fleets and business miles

AMHERST, N.Y., Nov. 17, 2017 /PRNewswire/ -- Fuel prices were over $3 a gallon for almost four years - that was in 2011, 2012, 2013 and for most of 2014. And in some areas, the price was above $4 a gallon – San Francisco on the west coast, Chicago in the Midwest and Boston in the northeast. For the following three years - 2015, 2016, and 2017 - the price of gas was relatively stable around the $2.50 per gallon mark.

Unfortunately, gas prices cannot be forecasted, and this unpredictable movement of fuel prices can negatively impact budget expense performance. The small changes in cost per gallon of fuel can balloon over time -  an extra $1 per gallon over one million miles is worth about $50,000 per year. (One million miles is 50 drivers averaging 20,000 miles per year.)

The issue for businesses is, it is almost impossible to separate the business miles a business should be paying for, from the personal miles people also drive.

Now though, with current GPS positioning and Google maps technology, tools like the Mi-Route exist to separate business and personal miles. CarData launched version 2.0 of Mobile Interactive Route – Mi-Route – this year.

Mi-Route allows drivers to separate business trips from personal trips directly on their cellular phones. And businesses pay for business miles only. It's not possible to change the price of gas, but Mi-Route helps ensure a business pays for business miles and not personal.

The value of removing personal miles is approximately a 17% reduction in gas expenses. On one million miles that is $200,000. (Gas expense is 20 cents per mile.)

Contact CarData to request a historical printout of the gas prices in your city or state. To manage fuel expenses better, then ask about CarData's Mi-Route app too.

About CarData Consultants: CarData provides precision vehicle reimbursement programs for the modern, mobile workforce. CarData services save money, reduce risk, and make it easier for drivers. CarData programs are compliant with the IRS and the CRA.

CarData conducts its own primary research on vehicle insurance premiums, and uses publicly available sources including state departments of insurance, and vehicle insurance websites.

MEDIA Contact: Megan Dean 
Marketing Communications | CarData Consultants Inc.
Direct: 303-434-3307 | FAX: 929-235-7525
185500@email4pr.com 
www.cardataconsultants.com

View original content with multimedia:http://www.prnewswire.com/news-releases/when-gas-prices-fluctuate-businesses-can-easily-save-money-by-tracking-with-mobile-interactive-route-300558159.html

SOURCE CarData Consultants

Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls

SILVER SPRING, Md., Nov. 17, 2017 /PRNewswire-USNewswire/ -- It's been nine weeks since Hurricane Maria made landfall on Puerto Rico and the island continues to struggle to recover from the devastation brought by this storm, as well as Hurricane Irma. 

As I've commented on previously, the medical products industry has a significant presence in Puerto Rico, and the disruption to this industry has had ramifications for patients both on the island and throughout the U.S. The FDA has been working closely with federal and Puerto Rican authorities to help stabilize the medical products manufacturing sector. We're taking steps to mitigate or avert product shortages but we've still seen shortages of certain medically important products, some of which are sourced primarily or only in Puerto Rico.

Most significantly to date, hospitals across the country are reporting shortages of IV fluids, particularly sodium chloride 0.9% injection bags – a type of saline bag. Saline IV fluids, which are used to inject drugs intravenously in hospital and outpatient settings, have been intermittently in shortage dating back to 2014. However, despite our best efforts, the situation in Puerto Rico has greatly exacerbated this supply issue. The FDA understands the concerns and impact of the ongoing shortages of IV solutions. These products have been on the list of approximately 90 medical products (which includes biologics, devices and drugs) that the FDA has been monitoring since the storm hit, and the FDA is actively working to address the shortage. Among the steps the FDA is taking, in conjunction with manufacturers of these products:

• temporarily allowing the importation of IV saline products from facilities outside of the U.S.;
• encouraging the expansion of production at existing facilities to meet shortfalls; and
• expediting our review of new product applications that will help address this shortage.

For instance, we're working with one supplier, Baxter, to help them restore operations in their Puerto Ricofacilities and move critical ingredients and products onto and off the island. Additionally, the FDA recently approved IV solution products from Fresenius Kabi and Laboratorios Grifols. Both companies are expected to increase production of saline products in the coming weeks. We believe steps like these will help to improve the shortage situation over time. 

Beyond these regulatory measures, given the extraordinary situation in Puerto Rico, we have also been working closely with local and federal authorities, and manufacturers of saline and other products, to help address the needs caused by challenges to the basic infrastructure on Puerto Rico. This includes steps to help a subset of critical production facilities gain access to fuel or generators. We're also connecting companies to other parts of the federal and local government to help clear roads or secure transport priority to import critical raw ingredients.

Going forward, access to reliable power is integral to ensuring Puerto Rico-based medical product manufacturers return to full production capacity quickly. This is the focus of a lot of effort. Unfortunately, most manufacturers are still relying on generator power, and even those that have returned to the electrical grid continue to face interruptions as the grid is rebuilt. 

As part of our efforts to reduce the risk of further shortages, the FDA has been working with federal and local government partners to prioritize a small number of critical facilities based on public health needs, including those plants that manufacture IV saline bags, for consideration or prioritization to gain earlier access to the electrical grid. Federal and local authorities have been very responsive to these requests. We're hopeful that these companies manufacturing medically important products will see their power needs addressed on an accelerated basis. The FDA continues to encourage the companies with FDA-approved saline products to add capacity to meet U.S. demand. We're also working to identify additional potential manufacturers.  

That said, this shortage will require a sustained effort by industry, the agency and other partners to return to production levels that adequately meet the needs of patients. For our part, the FDA will continue to do all we can to address this shortage. We also want to discourage hoarding of products by some healthcare providers. We're concerned that shortages of some products may be exacerbated in part because of hoarding behavior.

In the meantime, the FDA encourages hospitals to consider clinical recommendations for managing the shortage of these IV fluids, including recommendations by the American Society of Health-System Pharmacists (ASHP) and the University of Utah. The recently released guidance Small-Volume Parenteral Solutions Shortages provides an outline for potential actions for organizations and healthcare professionals to consider in managing the shortage.

The FDA remains committed to fully supporting Puerto Rico's medical products industry, both as a key aspect of the island's recovery and in ensuring that Americans continue to have access to the products they need.

For more information:

• CDER statement on IV ShortageCenter for Drug Evaluation and Research statement on IV shortage
• FDA's drug shortages website on saline
• Commissioner Statement on Baxter
• FDA In Brief: Analysis on the important role of medical product manufacturing in Puerto Rico

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Media Inquiries: Lyndsay Meyer, 240-402-5345, lyndsay.meyer@fda.hhs.gov 
Consumer Inquiries: 888-INFO-FDA

 

View original content with multimedia:http://www.prnewswire.com/news-releases/statement-by-fda-commissioner-scott-gottlieb-md-on-efforts-to-address-impact-of-iv-fluid-shortages-following-hurricane-destruction-and-resolve-manufacturing-shortfalls-300558587.html

SOURCE U.S. Food and Drug Administration

Web Site: http://www.fda.gov 

Our Commitment to Community Well Being

MUMBAI, India, November 17, 2017 /PRNewswire/ --

TechnipFMC, a global leader in oil and gas projects, technologies, systems and services is committed to sustainable development of local communities across their presence worldwide. In India, the Company has taken up several initiatives under Corporate Social Responsibility (CSR) program to demonstrate the act of compassion towards the well-being of local community. True to the purpose, at TechnipFMC India* we proudly refer our CSR program as 'Seed of Hope'.

To view the Multimedia News Release, please click: https://www.multivu.com/players/uk/8224251-technipfmc-community-well-being/  

Here is a snapshot of few of our activities aiming to instil Seed of Hope across India where we operate.

Time Period: FY 2016-17

In Delhi, with a strength of over 1000 employees, we have established ourselves as Tier 1 EPC player and identified the areas in the vicinity of Delhi & NCR to initiate projects with long term impact in the field of education and sanitation. 

In order to support Swacch Bharat (Clean India) initiative of the Government of India, we have tied up with Divya Prem Seva Mission in Haridwar, Uttarakhand to construct 38 toilets in Bhogpur village in Rishikesh to provide sanitation facilities to the villagers. To further our support in education, a computer lab was set up in Father Agnel Balbhawan School in Greater Noida, U.P. In Banaras, through the Ashadiya Foundation, TechnipFMC sponsored education, medical and lifestyle expenses of orphaned girls.

TechnipFMC is present in Mumbai with a strength of 650 people and has kicked off significant community programs in Mumbai and Gujarat to support education for the girl child, integrateddevelopment for villages and providing necessary aid to drought affected farmers.  

Through the SOS Children's Villages of India present in Mumbai, we sponsored the education of 27 underprivileged girls to reinforce our commitment to Girl Empowerment Movement (GEM). We also made a donation to the NAAM Foundation to support drought-hit farmers in Maharashtra. In Ahmedabad, we have adopted twelve girl children of Vidya Mandir Residential School to sponsor their education fees till the completion of their school education.

In Dahej, Gujarat, TechnipFMC has set up its first Modular Manufacturing Yard in India and alongside our business commitment towards our stakeholders, we have adopted a local village, Suva at Vagra Block to promote integrated development in four fundamental areas:

• Improve education infrastructure and promote eLearning amongst students
• Encourage financial literacy and promote micro-enterprising
• Enhance awareness on healthcare, hygiene and sanitation, especially for pregnant women, lactating mothers and children
• Raise awareness on disaster management

To this purpose, we have collaborated with SEED, a leading CSR implementation agency. Watch the video on our initiatives at Suva Village.

Our Chennai Office with a strength of over 1000 employees has been in the forefront in performing several projects in Onshore / Offshore / Subsea segments both locally as well as globally and is carrying out various programs to promote community development in the areas of education, health, women empowerment and environment

In Chennai, we have taken up the following CSR initiatives in 2016:

• Sponsoring education of hundred meritorious orphans through Seva Chakkra Samajam Trust
• As a company, Health, Safety and Environment are our top priorities, thus, through Ganesh Mandali Engine Valves (GMEV) Trust, TechnipFMC set up an ICU in Margaret Sydney Hospital to provide affordable healthcare to the underprivileged in society
• To promote clean energy, we have installed a Solar Panel Grid at a school in Karur, Tamil Nadu through Karur Lions Club Charitable Trust
• In order to empower women, in association with Association of Lady Entrepreneurs of Andhra Pradesh (ALEAP), we sponsored machinery to manufacture bio-degradable sanitary napkins and provided training to underprivileged women to earn their livelihood
• We sponsored therapeutic tools and aids for the differently-abled children of Authichudi School through the Swastik Trust in Kanchipuram, Tamil Nadu

In association with Indian Institute of Technology, Madras (IITM) we have initiated a four year long Sustainable Waste Management and Resource Recovery (SWR-RM) project to build a zero waste village in Kanchipuram.

Through IITM we have also executed C-4 Education Program in eleven schools in Chennai and West Bengal with an aim to promote education in rural areas where qualified teachers are rare. This program aims at mentoring of school children by students four classes senior to them.

*Technip India is a subsidy of TechnipFMC Group. For more information please contact: Swayantani Ghosh, Email: swayantani.ghosh@technipfmc.com  

 

     (Logo: http://mma.prnewswire.com/media/582584/TechnipFMC_Logo.jpg )

Video: 
     https://www.multivu.com/players/uk/8224251-technipfmc-community-well-being/